R1	Has_value Arg1:T3 Arg2:T4	
R2	Has_index Arg1:T5 Arg2:T6	
R3	Has_temporal Arg1:T3 Arg2:T5	
*	OR T1 T2
R4	AND Arg1:T10 Arg2:T11	
R5	Has_index Arg1:T12 Arg2:T13	
R6	Has_temporal Arg1:T10 Arg2:T12	
R7	Has_temporal Arg1:T14 Arg2:T15	
R8	Has_temporal Arg1:T9 Arg2:T17	
R9	Has_mood Arg1:T9 Arg2:T8	
R10	Has_index Arg1:T15 Arg2:T23	
R11	Has_index Arg1:T16 Arg2:T24	
R12	Has_index Arg1:T17 Arg2:T25	
R13	Has_index Arg1:T26 Arg2:T28	
*	OR T27 T29
R14	Has_temporal Arg1:T19 Arg2:T26	
R15	Has_mood Arg1:T32 Arg2:T31	
R16	Has_index Arg1:T33 Arg2:T34	
R17	Has_temporal Arg1:T32 Arg2:T33	
R18	Has_index Arg1:T36 Arg2:T37	
R19	Has_temporal Arg1:T35 Arg2:T36	
R20	Has_context Arg1:T38 Arg2:T35	
R21	Has_mood Arg1:T41 Arg2:T21	
*	OR T40 T42
R22	Has_qualifier Arg1:T22 Arg2:T40	
R23	Has_temporal Arg1:T14 Arg2:T16	
R24	Has_temporal Arg1:T19 Arg2:T27	
T1	Person 0 4	Male
T2	Person 8 14	female
T3	Person 28 31	age
T4	Value 15 24	=18 years
T5	Temporal 32 42	at Visit 1
T6	Reference_point 35 42	Visit 1
T7	Condition 63 65	CF
T10	Drug 241 255	IV antibiotics
T11	Condition 262 284	pulmonary exacerbation
T12	Temporal 189 211	At the time of Visit 1
T13	Reference_point 204 211	Visit 1
T14	Procedure 296 306	spirometry
T15	Temporal 307 317	at Visit 1
T16	Temporal 307 309;322 329	at Visit 2
T17	Temporal 364 374	at Visit 3
T8	Mood 334 352	willing to perform
T9	Procedure 353 363	spirometry
T23	Reference_point 310 317	Visit 1
T24	Reference_point 322 329	Visit 2
T25	Reference_point 367 374	Visit 3
T19	Procedure 390 409	CRISS questionnaire
T26	Temporal 410 420	at Visit 1
T27	Temporal 410 412;425 432	at Visit 2
T28	Reference_point 413 420	Visit 1
T29	Reference_point 425 432	Visit 2
T31	Mood 437 456	willing to complete
T32	Procedure 461 525	Cystic Fibrosis Respiratory Symptoms Diary (CFRSD) questionnaire
T33	Temporal 526 536	at Visit 3
T34	Reference_point 529 536	Visit 3
T35	Observation 77 154	Enrolled in the Cystic Fibrosis Foundation National Patient Registry (CFFNPR)
T36	Temporal 155 171	prior to Visit 1
T37	Reference_point 164 171	Visit 1
T38	Visit 173 181	US sites
T20	Mood 538 548	Willing to
T39	Non-representable 549 661	adhere to a specific treatment duration determined by initial response to treatment and subsequent randomization
T21	Mood 663 673	Willing to
T41	Procedure 685 702	follow up Visit 3
T22	Observation 704 728	Written informed consent
T40	Qualifier 738 754	from the subject
T42	Qualifier 738 746;758 788	from the subject's legal representative
